Kaleido Biosciences, Inc. (KLDO)

USD 0.0

(0.0%)

Annual Income Statements

(In USD)
Breakdown 2022 2021 2020 2019 2018 2017
Revenue - 1.1 Million 975 Thousand - - -
Cost of Revenue - 2.35 Million 55.96 Thousand 1.31 Million - -
Gross Profit - -1.25 Million 919.03 Thousand -1.31 Million - -
Operating Expenses - 88.77 Million 79.84 Million 86.66 Million 60.68 Million 27.03 Million
Selling, General and Administrative Expenses - 20.96 Million 23.88 Million 22.42 Million 18.62 Million 6.03 Million
Research and Development Expenses - 67.8 Million 55.96 Million 64.23 Million 42.06 Million 20.99 Million
Other Expenses - 145 Thousand -2.74 Million 329 Thousand -256 Thousand -17 Thousand
Cost and Expenses - 88.77 Million 79.84 Million 86.66 Million 60.68 Million 27.03 Million
Operating Income - -87.66 Million -78.87 Million -86.66 Million -60.68 Million -27.03 Million
Interest Expense - 2.83 Million 2.8 Million 977 Thousand 1 Million 435 Thousand
Income Tax Expense - 2.98 Million -1.82 Million -1.31 Million -56 Thousand -94 Thousand
Earnings before Tax - -90.28 Million -81.61 Million -86.33 Million -61.74 Million -27.55 Million
Net Income - -93.27 Million -79.79 Million -85.01 Million -61.74 Million -27.55 Million
Earnings Per Share Basic - -2.23 -2.39 -3.31 -2.10 -1.23
Earnings Per Share Diluted - -2.23 -2.39 -3.31 -2.10 -1.23
Weighted Average Shares Outstanding - 41.85 Million 33.45 Million 25.7 Million 29.39 Million 22.41 Million
Weighted Average Shares Outstanding (Diluted) - 41.85 Million 33.45 Million 25.7 Million 29.39 Million 22.41 Million
Gross Margin - -1.14 0.94 - - -
EBIT Margin - -77.08 -80.90 - - -
Profit Margin - -84.48 -81.84 - - -
EBITDA - -85.09 Million -76.99 Million -86.66 Million -59.02 Million -26.69 Million
Earnings Before Tax Margin - -79.41 -80.90 - - -

Income Statement Charts